ARCH Venture Partners raises $400m
The US firm has raised $400 million for its seventh fund, to focus on early stage investments in biotechnology, advanced materials and specialty semiconductors.
16 January 2013•1 min read
The US firm has raised $400 million for its seventh fund, to focus on early stage investments in biotechnology, advanced materials and specialty semiconductors.
